Clinical Trial Update: Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the budesonide/formoterol combination in repeated AMP provocations for asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide/Formoterol (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 4 | Status: COMPLETED